

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 4.68094440 |
| 2 | polyketide metabolic process (GO:0030638) | 4.60553918 |
| 3 | doxorubicin metabolic process (GO:0044598) | 4.60553918 |
| 4 | daunorubicin metabolic process (GO:0044597) | 4.60553918 |
| 5 | low-density lipoprotein particle clearance (GO:0034383) | 4.28540929 |
| 6 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.13370307 |
| 7 | skin morphogenesis (GO:0043589) | 4.12925949 |
| 8 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.00170053 |
| 9 | epithelial cell-cell adhesion (GO:0090136) | 3.57375176 |
| 10 | mitotic chromosome condensation (GO:0007076) | 3.56359020 |
| 11 | membrane raft organization (GO:0031579) | 3.47419060 |
| 12 | heterochromatin organization (GO:0070828) | 3.39804612 |
| 13 | protein hydroxylation (GO:0018126) | 3.38020414 |
| 14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.34984687 |
| 15 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.33075075 |
| 16 | regulation of early endosome to late endosome transport (GO:2000641) | 3.32931655 |
| 17 | nuclear pore complex assembly (GO:0051292) | 3.31343756 |
| 18 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.29953379 |
| 19 | cell adhesion mediated by integrin (GO:0033627) | 3.28594153 |
| 20 | hypotonic response (GO:0006971) | 3.25708085 |
| 21 | ribosome assembly (GO:0042255) | 3.21912152 |
| 22 | nuclear pore organization (GO:0006999) | 3.20863186 |
| 23 | glucose catabolic process (GO:0006007) | 3.20860884 |
| 24 | COPII vesicle coating (GO:0048208) | 3.18757068 |
| 25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.15895745 |
| 26 | membrane protein ectodomain proteolysis (GO:0006509) | 3.14023601 |
| 27 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.12981644 |
| 28 | substrate-dependent cell migration (GO:0006929) | 3.11370756 |
| 29 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.07173107 |
| 30 | cellular protein complex localization (GO:0034629) | 3.07080006 |
| 31 | hemidesmosome assembly (GO:0031581) | 3.06537283 |
| 32 | iron ion import (GO:0097286) | 3.03773207 |
| 33 | regulation of integrin activation (GO:0033623) | 3.01202243 |
| 34 | protein retention in ER lumen (GO:0006621) | 3.01077628 |
| 35 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.99071706 |
| 36 | cell-substrate junction assembly (GO:0007044) | 2.98212260 |
| 37 | wound healing, spreading of epidermal cells (GO:0035313) | 2.97955760 |
| 38 | endothelial cell morphogenesis (GO:0001886) | 2.96826293 |
| 39 | stress fiber assembly (GO:0043149) | 2.96560425 |
| 40 | tetrahydrofolate metabolic process (GO:0046653) | 2.95525876 |
| 41 | hyaluronan catabolic process (GO:0030214) | 2.94600935 |
| 42 | vesicle coating (GO:0006901) | 2.94274751 |
| 43 | regulation of cholesterol storage (GO:0010885) | 2.94042269 |
| 44 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.93571292 |
| 45 | mesodermal cell differentiation (GO:0048333) | 2.93402209 |
| 46 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.93136713 |
| 47 | cellular response to vitamin D (GO:0071305) | 2.92133781 |
| 48 | mammary gland epithelial cell proliferation (GO:0033598) | 2.90641509 |
| 49 | glycoside metabolic process (GO:0016137) | 2.90468295 |
| 50 | myeloid cell homeostasis (GO:0002262) | 2.90326850 |
| 51 | regulation of translational fidelity (GO:0006450) | 2.89638079 |
| 52 | barbed-end actin filament capping (GO:0051016) | 2.87157827 |
| 53 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.86902801 |
| 54 | apoptotic cell clearance (GO:0043277) | 2.83450344 |
| 55 | positive regulation of extracellular matrix organization (GO:1903055) | 2.83243285 |
| 56 | regulation of gene silencing by RNA (GO:0060966) | 2.83213677 |
| 57 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.83213677 |
| 58 | regulation of gene silencing by miRNA (GO:0060964) | 2.83213677 |
| 59 | * nucleobase-containing small molecule interconversion (GO:0015949) | 2.81338661 |
| 60 | DNA unwinding involved in DNA replication (GO:0006268) | 2.80545678 |
| 61 | T cell apoptotic process (GO:0070231) | 2.79084307 |
| 62 | focal adhesion assembly (GO:0048041) | 2.73494522 |
| 63 | cell-substrate adherens junction assembly (GO:0007045) | 2.73494522 |
| 64 | glucose 6-phosphate metabolic process (GO:0051156) | 2.72987958 |
| 65 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.72724213 |
| 66 | positive regulation of p38MAPK cascade (GO:1900745) | 2.72029212 |
| 67 | mitotic cytokinesis (GO:0000281) | 2.71158954 |
| 68 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.69056224 |
| 69 | pinocytosis (GO:0006907) | 2.68531832 |
| 70 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.68175711 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.67871819 |
| 72 | adherens junction assembly (GO:0034333) | 2.67821597 |
| 73 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.67429675 |
| 74 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.67429675 |
| 75 | modulation by symbiont of host immune response (GO:0052553) | 2.67429675 |
| 76 | positive regulation by symbiont of host defense response (GO:0052509) | 2.67429675 |
| 77 | modulation by symbiont of host defense response (GO:0052031) | 2.67429675 |
| 78 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.67429675 |
| 79 | protein localization to microtubule (GO:0035372) | 2.67155889 |
| 80 | regulation of podosome assembly (GO:0071801) | 2.66434516 |
| 81 | regulation of cholesterol homeostasis (GO:2000188) | 2.64682186 |
| 82 | ER-nucleus signaling pathway (GO:0006984) | 2.64541947 |
| 83 | mRNA stabilization (GO:0048255) | 2.64419410 |
| 84 | RNA stabilization (GO:0043489) | 2.64419410 |
| 85 | regulation of hippo signaling (GO:0035330) | 2.64227906 |
| 86 | IMP biosynthetic process (GO:0006188) | 2.63845553 |
| 87 | regulation of translational termination (GO:0006449) | 2.63827245 |
| 88 | cellular response to vitamin (GO:0071295) | 2.63568175 |
| 89 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.62648134 |
| 90 | basement membrane organization (GO:0071711) | 2.62643970 |
| 91 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.60769609 |
| 92 | mitotic metaphase plate congression (GO:0007080) | 2.60411395 |
| 93 | activation of Rac GTPase activity (GO:0032863) | 2.59303012 |
| 94 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.58227306 |
| 95 | apoptotic process involved in morphogenesis (GO:0060561) | 2.55890341 |
| 96 | natural killer cell mediated immunity (GO:0002228) | 2.55426880 |
| 97 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.55426880 |
| 98 | negative regulation of anoikis (GO:2000811) | 2.55103467 |
| 99 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.54314072 |
| 100 | regulation of interferon-alpha production (GO:0032647) | 2.53915265 |
| 101 | maternal placenta development (GO:0001893) | 2.53536570 |
| 102 | regulation of mitotic spindle organization (GO:0060236) | 2.53503101 |
| 103 | positive regulation of nuclease activity (GO:0032075) | 2.53347817 |
| 104 | protein complex localization (GO:0031503) | 2.53162442 |
| 105 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.52248792 |
| 106 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.52094233 |
| 107 | cellular response to unfolded protein (GO:0034620) | 2.52018139 |
| 108 | glycosphingolipid catabolic process (GO:0046479) | 2.51857947 |
| 109 | plasma lipoprotein particle clearance (GO:0034381) | 2.51326371 |
| 110 | peptidyl-proline hydroxylation (GO:0019511) | 2.49896075 |
| 111 | hippo signaling (GO:0035329) | 2.49348957 |
| 112 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.48821415 |
| 113 | dosage compensation (GO:0007549) | 2.48528940 |
| 114 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.48085928 |
| 115 | mitotic nuclear envelope disassembly (GO:0007077) | 2.47390425 |
| 116 | NLS-bearing protein import into nucleus (GO:0006607) | 2.47263263 |
| 117 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.46124777 |
| 118 | ER overload response (GO:0006983) | 2.45017851 |
| 119 | hepatocyte differentiation (GO:0070365) | 2.44983367 |
| 120 | mitotic sister chromatid segregation (GO:0000070) | 2.44778905 |
| 121 | pre-miRNA processing (GO:0031054) | 2.44316855 |
| 122 | establishment of integrated proviral latency (GO:0075713) | 2.43640408 |
| 123 | protein localization to chromosome, centromeric region (GO:0071459) | 2.42308150 |
| 124 | response to peptidoglycan (GO:0032494) | 2.42187116 |
| 125 | positive regulation of osteoblast proliferation (GO:0033690) | 2.41650952 |
| 126 | glycolipid catabolic process (GO:0019377) | 2.40981526 |
| 127 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.40218659 |
| 128 | protein maturation by protein folding (GO:0022417) | 2.39333012 |
| 129 | nuclear envelope disassembly (GO:0051081) | 2.39029656 |
| 130 | membrane disassembly (GO:0030397) | 2.39029656 |
| 131 | regulation of protein export from nucleus (GO:0046825) | 2.38538983 |
| 132 | embryonic process involved in female pregnancy (GO:0060136) | 2.38511771 |
| 133 | response to arsenic-containing substance (GO:0046685) | 2.38491618 |
| 134 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.37600860 |
| 135 | IMP metabolic process (GO:0046040) | 2.37024167 |
| 136 | protein localization to kinetochore (GO:0034501) | 2.36961958 |
| 137 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.36080833 |
| 138 | regulation of chemokine biosynthetic process (GO:0045073) | 2.35818305 |
| 139 | pentose-phosphate shunt (GO:0006098) | 2.34747621 |
| 140 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.34661787 |
| 141 | pore complex assembly (GO:0046931) | 2.33661674 |
| 142 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.32245386 |
| 143 | positive regulation of lipid storage (GO:0010884) | 2.32053380 |
| 144 | macroautophagy (GO:0016236) | 2.29549783 |
| 145 | endodermal cell differentiation (GO:0035987) | 2.28340865 |
| 146 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.27874444 |
| 147 | B cell mediated immunity (GO:0019724) | 2.27402332 |
| 148 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.25141667 |
| 149 | cysteine metabolic process (GO:0006534) | 2.23386873 |
| 150 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.22634398 |
| 151 | negative regulation of fatty acid transport (GO:2000192) | 2.22367716 |
| 152 | lymphocyte apoptotic process (GO:0070227) | 2.22187211 |
| 153 | negative regulation of interleukin-12 production (GO:0032695) | 2.21853757 |
| 154 | COPI coating of Golgi vesicle (GO:0048205) | 2.21400023 |
| 155 | Golgi transport vesicle coating (GO:0048200) | 2.21400023 |
| 156 | negative regulation of fibrinolysis (GO:0051918) | 2.21209007 |
| 157 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.20871589 |
| 158 | wound healing, spreading of cells (GO:0044319) | 2.20825383 |
| 159 | response to laminar fluid shear stress (GO:0034616) | 2.20720410 |
| 160 | regulation of protein heterodimerization activity (GO:0043497) | 2.20333907 |
| 161 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.20153873 |
| 162 | chromatin assembly (GO:0031497) | 2.19564203 |
| 163 | response to UV-C (GO:0010225) | 2.19417105 |
| 164 | developmental programmed cell death (GO:0010623) | 2.19406666 |
| 165 | NADPH regeneration (GO:0006740) | 2.18403130 |
| 166 | positive regulation of protein oligomerization (GO:0032461) | 2.17663931 |
| 167 | leukocyte apoptotic process (GO:0071887) | 2.17234190 |
| 168 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.15684435 |
| 169 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.15450706 |
| 170 | positive regulation of interferon-beta production (GO:0032728) | 2.14504927 |
| 171 | immunoglobulin mediated immune response (GO:0016064) | 2.14432713 |
| 172 | acute-phase response (GO:0006953) | 2.14129387 |
| 173 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.13438816 |
| 174 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.13301916 |
| 175 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.12252730 |
| 176 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.11594005 |
| 177 | response to muramyl dipeptide (GO:0032495) | 2.10860622 |
| 178 | folic acid-containing compound metabolic process (GO:0006760) | 2.10524336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.05524289 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.17912362 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.55443891 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.53640291 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.94234852 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.67969664 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26178610 |
| 8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.22399839 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.13762151 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00875870 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00149814 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.99028364 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.96417644 |
| 14 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.92413356 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.88894278 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88611878 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87070317 |
| 18 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.85708095 |
| 19 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.85001545 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84266803 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81699023 |
| 22 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.75449955 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72125898 |
| 24 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.71820899 |
| 25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.69207768 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66642267 |
| 27 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.66639768 |
| 28 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63692823 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60138030 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.58757302 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56136010 |
| 32 | ATF3_27146783_Chip-Seq_COLON_Human | 1.55637026 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55338700 |
| 34 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53747316 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.53616097 |
| 36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53436380 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.50776112 |
| 38 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.50275733 |
| 39 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49322298 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47940622 |
| 41 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.47290182 |
| 42 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.46741087 |
| 43 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.46470549 |
| 44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.45817917 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45477846 |
| 46 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.44589065 |
| 47 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44557161 |
| 48 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.44172598 |
| 49 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43740839 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43426290 |
| 51 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.40999680 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40724333 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40053235 |
| 54 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39693180 |
| 55 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.39202324 |
| 56 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.37574301 |
| 57 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37526045 |
| 58 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.37150004 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.36476642 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35866310 |
| 61 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.31789119 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30289195 |
| 63 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28820743 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27895002 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27564307 |
| 66 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27158704 |
| 67 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.25882159 |
| 68 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.25882159 |
| 69 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.25882159 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24174212 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23855475 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22917766 |
| 73 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22366452 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21798446 |
| 75 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21422036 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21393520 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20490965 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19087308 |
| 79 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18491493 |
| 80 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18352946 |
| 81 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.17223478 |
| 82 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.16552458 |
| 83 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16186823 |
| 84 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16186823 |
| 85 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16052020 |
| 86 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15533273 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15337020 |
| 88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14499366 |
| 89 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14211205 |
| 90 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.14102801 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13712448 |
| 92 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13547274 |
| 93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.13399550 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12807642 |
| 95 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12639293 |
| 96 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11579316 |
| 97 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11305777 |
| 98 | * MAF_26560356_Chip-Seq_TH1_Human | 1.11300825 |
| 99 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10575793 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10529951 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10111866 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08836785 |
| 103 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08793954 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08543706 |
| 105 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07839019 |
| 106 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.07648138 |
| 107 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.07276959 |
| 108 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.04683225 |
| 109 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04323383 |
| 110 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03905811 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03404624 |
| 112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02931162 |
| 113 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02617172 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02241292 |
| 115 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.02098243 |
| 116 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01371259 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01046576 |
| 118 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00903495 |
| 119 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.00771918 |
| 120 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.00342824 |
| 121 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.99450099 |
| 122 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98371842 |
| 123 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98095251 |
| 124 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97960874 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97934424 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97584169 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96508484 |
| 128 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95827802 |
| 129 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95787048 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95555255 |
| 131 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95500426 |
| 132 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.95208630 |
| 133 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94994704 |
| 134 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94970607 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93632758 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92933592 |
| 137 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92388899 |
| 138 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92030992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.88862851 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 3.84849291 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.24657531 |
| 4 | MP0004272_abnormal_basement_membrane | 2.76844706 |
| 5 | MP0005076_abnormal_cell_differentiation | 2.49269224 |
| 6 | MP0004233_abnormal_muscle_weight | 2.39248316 |
| 7 | MP0003303_peritoneal_inflammation | 2.36799496 |
| 8 | MP0003566_abnormal_cell_adhesion | 2.23428861 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.16527408 |
| 10 | MP0005451_abnormal_body_composition | 2.16208962 |
| 11 | MP0005360_urolithiasis | 2.12961358 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.07456259 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.05361078 |
| 14 | MP0010307_abnormal_tumor_latency | 2.05116971 |
| 15 | MP0003436_decreased_susceptibility_to | 2.04838647 |
| 16 | MP0009840_abnormal_foam_cell | 2.00045794 |
| 17 | MP0003941_abnormal_skin_development | 1.96289235 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 1.90492702 |
| 19 | MP0009278_abnormal_bone_marrow | 1.88960023 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.87005878 |
| 21 | MP0005023_abnormal_wound_healing | 1.74714703 |
| 22 | MP0004947_skin_inflammation | 1.64592240 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.57928449 |
| 24 | MP0001348_abnormal_lacrimal_gland | 1.52559059 |
| 25 | MP0009785_altered_susceptibility_to | 1.52427493 |
| 26 | MP0009053_abnormal_anal_canal | 1.50133849 |
| 27 | MP0001849_ear_inflammation | 1.49580461 |
| 28 | MP0000858_altered_metastatic_potential | 1.49414915 |
| 29 | MP0003453_abnormal_keratinocyte_physiol | 1.47279616 |
| 30 | MP0003448_altered_tumor_morphology | 1.42193996 |
| 31 | MP0003091_abnormal_cell_migration | 1.38973627 |
| 32 | MP0003252_abnormal_bile_duct | 1.34118853 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.32065608 |
| 34 | MP0003279_aneurysm | 1.28686149 |
| 35 | MP0000490_abnormal_crypts_of | 1.27647508 |
| 36 | MP0002896_abnormal_bone_mineralization | 1.27599877 |
| 37 | MP0005197_abnormal_uvea_morphology | 1.25663257 |
| 38 | MP0004197_abnormal_fetal_growth/weight/ | 1.24931809 |
| 39 | MP0006082_CNS_inflammation | 1.24624387 |
| 40 | MP0000733_abnormal_muscle_development | 1.22847484 |
| 41 | MP0003693_abnormal_embryo_hatching | 1.22661245 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.22179544 |
| 43 | MP0009697_abnormal_copulation | 1.21942745 |
| 44 | MP0005257_abnormal_intraocular_pressure | 1.20964216 |
| 45 | MP0001958_emphysema | 1.18378448 |
| 46 | MP0005085_abnormal_gallbladder_physiolo | 1.16317542 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.15286628 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.15286628 |
| 49 | * MP0001730_embryonic_growth_arrest | 1.13544153 |
| 50 | MP0008260_abnormal_autophagy | 1.13224737 |
| 51 | * MP0000350_abnormal_cell_proliferation | 1.12370633 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.11992926 |
| 53 | MP0005083_abnormal_biliary_tract | 1.11775736 |
| 54 | MP0005621_abnormal_cell_physiology | 1.11631724 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.11287025 |
| 56 | MP0002419_abnormal_innate_immunity | 1.10669859 |
| 57 | MP0003186_abnormal_redox_activity | 1.10042478 |
| 58 | MP0010030_abnormal_orbit_morphology | 1.09435397 |
| 59 | MP0005164_abnormal_response_to | 1.09370372 |
| 60 | * MP0002086_abnormal_extraembryonic_tissu | 1.08923818 |
| 61 | MP0005025_abnormal_response_to | 1.07466527 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.06773706 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.06005814 |
| 64 | MP0003077_abnormal_cell_cycle | 1.05852636 |
| 65 | MP0008932_abnormal_embryonic_tissue | 1.05002668 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.04856994 |
| 67 | MP0000685_abnormal_immune_system | 1.04822975 |
| 68 | MP0000609_abnormal_liver_physiology | 1.04104440 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.03296297 |
| 70 | MP0005365_abnormal_bile_salt | 1.03020633 |
| 71 | MP0004858_abnormal_nervous_system | 1.02556102 |
| 72 | MP0001915_intracranial_hemorrhage | 1.01690084 |
| 73 | MP0005000_abnormal_immune_tolerance | 1.01232758 |
| 74 | MP0002088_abnormal_embryonic_growth/wei | 1.01108772 |
| 75 | MP0003828_pulmonary_edema | 1.00812222 |
| 76 | MP0003111_abnormal_nucleus_morphology | 1.00754031 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.00749859 |
| 78 | MP0003984_embryonic_growth_retardation | 1.00376749 |
| 79 | MP0000767_abnormal_smooth_muscle | 1.00090900 |
| 80 | MP0005165_increased_susceptibility_to | 0.99734681 |
| 81 | * MP0001672_abnormal_embryogenesis/_devel | 0.98247516 |
| 82 | * MP0005380_embryogenesis_phenotype | 0.98247516 |
| 83 | MP0010094_abnormal_chromosome_stability | 0.97878548 |
| 84 | MP0000598_abnormal_liver_morphology | 0.96801606 |
| 85 | MP0005501_abnormal_skin_physiology | 0.95579263 |
| 86 | MP0001835_abnormal_antigen_presentation | 0.94942391 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 0.94518708 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94244770 |
| 89 | MP0002405_respiratory_system_inflammati | 0.93757882 |
| 90 | MP0000627_abnormal_mammary_gland | 0.92241809 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.91711786 |
| 92 | MP0002452_abnormal_antigen_presenting | 0.91383642 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.90712694 |
| 94 | MP0005275_abnormal_skin_tensile | 0.90693448 |
| 95 | MP0006054_spinal_hemorrhage | 0.90232456 |
| 96 | MP0001243_abnormal_dermal_layer | 0.90019623 |
| 97 | MP0009333_abnormal_splenocyte_physiolog | 0.89868201 |
| 98 | MP0000747_muscle_weakness | 0.89648945 |
| 99 | MP0008007_abnormal_cellular_replicative | 0.88238095 |
| 100 | MP0002254_reproductive_system_inflammat | 0.87260883 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.86188731 |
| 102 | MP0000477_abnormal_intestine_morphology | 0.85778532 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.85516221 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.85496011 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.85018160 |
| 106 | MP0000762_abnormal_tongue_morphology | 0.84498830 |
| 107 | MP0000537_abnormal_urethra_morphology | 0.84074116 |
| 108 | * MP0001697_abnormal_embryo_size | 0.83764778 |
| 109 | MP0001661_extended_life_span | 0.83750601 |
| 110 | MP0000371_diluted_coat_color | 0.83719939 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.83672870 |
| 112 | MP0005193_abnormal_anterior_eye | 0.83123901 |
| 113 | * MP0002084_abnormal_developmental_patter | 0.82633092 |
| 114 | MP0004264_abnormal_extraembryonic_tissu | 0.82615982 |
| 115 | MP0005384_cellular_phenotype | 0.82314932 |
| 116 | MP0000358_abnormal_cell_content/ | 0.82079599 |
| 117 | MP0002796_impaired_skin_barrier | 0.81427498 |
| 118 | MP0002269_muscular_atrophy | 0.80679927 |
| 119 | MP0003890_abnormal_embryonic-extraembry | 0.80351614 |
| 120 | MP0002998_abnormal_bone_remodeling | 0.80329232 |
| 121 | MP0008469_abnormal_protein_level | 0.80237247 |
| 122 | MP0002060_abnormal_skin_morphology | 0.80205488 |
| 123 | * MP0002080_prenatal_lethality | 0.79633264 |
| 124 | MP0002019_abnormal_tumor_incidence | 0.79505930 |
| 125 | MP0000428_abnormal_craniofacial_morphol | 0.78532435 |
| 126 | MP0005623_abnormal_meninges_morphology | 0.78354553 |
| 127 | MP0000343_altered_response_to | 0.78148267 |
| 128 | MP0009780_abnormal_chondrocyte_physiolo | 0.76921994 |
| 129 | MP0001542_abnormal_bone_strength | 0.76920350 |
| 130 | MP0009763_increased_sensitivity_to | 0.76910940 |
| 131 | MP0001853_heart_inflammation | 0.76308544 |
| 132 | MP0001666_abnormal_nutrient_absorption | 0.75498645 |
| 133 | MP0000751_myopathy | 0.74900931 |
| 134 | MP0002723_abnormal_immune_serum | 0.74783777 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.74673116 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.74496412 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.73253197 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.73161179 |
| 139 | MP0009764_decreased_sensitivity_to | 0.73007234 |
| 140 | MP0002148_abnormal_hypersensitivity_rea | 0.72781387 |
| 141 | MP0000749_muscle_degeneration | 0.72754266 |
| 142 | MP0010678_abnormal_skin_adnexa | 0.72608137 |
| 143 | MP0004185_abnormal_adipocyte_glucose | 0.72469208 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.72350060 |
| 145 | MP0001800_abnormal_humoral_immune | 0.71835091 |
| 146 | * MP0002085_abnormal_embryonic_tissue | 0.71205251 |
| 147 | MP0005408_hypopigmentation | 0.69455491 |
| 148 | MP0003868_abnormal_feces_composition | 0.68363610 |
| 149 | MP0002295_abnormal_pulmonary_circulatio | 0.68249720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Short nail (HP:0001799) | 3.84536343 |
| 2 | Arterial tortuosity (HP:0005116) | 3.39104276 |
| 3 | Vascular tortuosity (HP:0004948) | 3.32387950 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.13217451 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.94740858 |
| 6 | Spastic diplegia (HP:0001264) | 2.93865395 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.85201040 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.85201040 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 2.85201040 |
| 10 | Hyperacusis (HP:0010780) | 2.81367451 |
| 11 | Broad face (HP:0000283) | 2.80791566 |
| 12 | Myocardial infarction (HP:0001658) | 2.77904338 |
| 13 | Peritonitis (HP:0002586) | 2.77837825 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.77784838 |
| 15 | Protrusio acetabuli (HP:0003179) | 2.76042616 |
| 16 | Distal lower limb amyotrophy (HP:0008944) | 2.74005112 |
| 17 | Wormian bones (HP:0002645) | 2.69624525 |
| 18 | Aortic dissection (HP:0002647) | 2.67364715 |
| 19 | Ulnar bowing (HP:0003031) | 2.63891921 |
| 20 | Spinal rigidity (HP:0003306) | 2.61111517 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.59487544 |
| 22 | Increased density of long bones (HP:0006392) | 2.51210120 |
| 23 | Tetraparesis (HP:0002273) | 2.50532268 |
| 24 | Aortic aneurysm (HP:0004942) | 2.49362484 |
| 25 | Subacute progressive viral hepatitis (HP:0006572) | 2.46028551 |
| 26 | Esophageal varix (HP:0002040) | 2.45750860 |
| 27 | Abnormality of proline metabolism (HP:0010907) | 2.44576167 |
| 28 | Hydroxyprolinuria (HP:0003080) | 2.44576167 |
| 29 | Increased mean platelet volume (HP:0011877) | 2.43887516 |
| 30 | Insidious onset (HP:0003587) | 2.43464907 |
| 31 | Termporal pattern (HP:0011008) | 2.43464907 |
| 32 | Spondylolisthesis (HP:0003302) | 2.43242573 |
| 33 | Elbow flexion contracture (HP:0002987) | 2.42241461 |
| 34 | Mitral stenosis (HP:0001718) | 2.42036589 |
| 35 | Cerebral aneurysm (HP:0004944) | 2.39598826 |
| 36 | Entropion (HP:0000621) | 2.33770773 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 2.33770061 |
| 38 | Atrophic scars (HP:0001075) | 2.29650406 |
| 39 | Abnormality of oral frenula (HP:0000190) | 2.29522746 |
| 40 | Syringomyelia (HP:0003396) | 2.28290223 |
| 41 | Spinal cord lesions (HP:0100561) | 2.28290223 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.27656891 |
| 43 | Deep venous thrombosis (HP:0002625) | 2.25921654 |
| 44 | Absent frontal sinuses (HP:0002688) | 2.25102372 |
| 45 | Distal upper limb amyotrophy (HP:0007149) | 2.22083308 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.22083308 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.20409454 |
| 48 | Abnormal platelet volume (HP:0011876) | 2.19349553 |
| 49 | Xanthomatosis (HP:0000991) | 2.17680105 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.17675297 |
| 51 | Hand muscle atrophy (HP:0009130) | 2.17250322 |
| 52 | Upper limb muscle weakness (HP:0003484) | 2.16193480 |
| 53 | Natal tooth (HP:0000695) | 2.14902057 |
| 54 | Fragile skin (HP:0001030) | 2.14778066 |
| 55 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.14341796 |
| 56 | Mitral regurgitation (HP:0001653) | 2.14042585 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.13936767 |
| 58 | Premature rupture of membranes (HP:0001788) | 2.13303500 |
| 59 | Metaphyseal cupping (HP:0003021) | 2.11874450 |
| 60 | Radial bowing (HP:0002986) | 2.11739567 |
| 61 | Cervical subluxation (HP:0003308) | 2.10281944 |
| 62 | Nuclear cataract (HP:0100018) | 2.10014727 |
| 63 | Abnormality of the umbilical cord (HP:0010881) | 2.08856454 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.08032368 |
| 65 | Intrahepatic cholestasis (HP:0001406) | 2.06461709 |
| 66 | Recurrent bacterial skin infections (HP:0005406) | 2.04986407 |
| 67 | Asymmetry of the thorax (HP:0001555) | 2.04364826 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.03970735 |
| 69 | Bladder diverticulum (HP:0000015) | 2.03016694 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02996938 |
| 71 | Abnormality of the acetabulum (HP:0003170) | 2.01988439 |
| 72 | Lower limb amyotrophy (HP:0007210) | 2.01775339 |
| 73 | Hematochezia (HP:0002573) | 2.00771310 |
| 74 | Shallow orbits (HP:0000586) | 2.00602948 |
| 75 | Increased connective tissue (HP:0009025) | 1.98256141 |
| 76 | Fused cervical vertebrae (HP:0002949) | 1.98248706 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 1.97577316 |
| 78 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97577316 |
| 79 | Hypobetalipoproteinemia (HP:0003563) | 1.97376205 |
| 80 | Cortical dysplasia (HP:0002539) | 1.97372164 |
| 81 | Upper motor neuron abnormality (HP:0002127) | 1.97247311 |
| 82 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.97090175 |
| 83 | Gastrointestinal carcinoma (HP:0002672) | 1.96190287 |
| 84 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.96190287 |
| 85 | Multiple enchondromatosis (HP:0005701) | 1.96007223 |
| 86 | Spinal cord compression (HP:0002176) | 1.94471150 |
| 87 | Back pain (HP:0003418) | 1.94283262 |
| 88 | Ankyloglossia (HP:0010296) | 1.94163693 |
| 89 | Rectal prolapse (HP:0002035) | 1.93768933 |
| 90 | Persistence of primary teeth (HP:0006335) | 1.93687975 |
| 91 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.93443242 |
| 92 | Micronodular cirrhosis (HP:0001413) | 1.92614098 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 1.92259596 |
| 94 | Blue sclerae (HP:0000592) | 1.90746134 |
| 95 | Abnormality of macrophages (HP:0004311) | 1.90556683 |
| 96 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.90485578 |
| 97 | Insomnia (HP:0100785) | 1.89770159 |
| 98 | Increased serum ferritin (HP:0003281) | 1.89486525 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 1.89175688 |
| 100 | Abnormality of dentin (HP:0010299) | 1.88556325 |
| 101 | Genu recurvatum (HP:0002816) | 1.88432645 |
| 102 | Limb-girdle muscle atrophy (HP:0003797) | 1.88025348 |
| 103 | Pseudobulbar signs (HP:0002200) | 1.87471223 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.86933756 |
| 105 | Abnormal ossification of hand bones (HP:0005921) | 1.85898651 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 1.85221581 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.84735069 |
| 108 | Bowed forearm bones (HP:0003956) | 1.84139146 |
| 109 | Bowing of the arm (HP:0006488) | 1.84139146 |
| 110 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.83722251 |
| 111 | Abnormality of carpal bone ossification (HP:0006257) | 1.83167673 |
| 112 | Thin bony cortex (HP:0002753) | 1.82791837 |
| 113 | Abnormality of the common coagulation pathway (HP:0010990) | 1.81387534 |
| 114 | Aneurysm (HP:0002617) | 1.81289583 |
| 115 | Orchitis (HP:0100796) | 1.81100802 |
| 116 | Aortic regurgitation (HP:0001659) | 1.80890676 |
| 117 | Mitral valve prolapse (HP:0001634) | 1.80424234 |
| 118 | Long toe (HP:0010511) | 1.79912177 |
| 119 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.78923402 |
| 120 | Turricephaly (HP:0000262) | 1.78405182 |
| 121 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.78279378 |
| 122 | Rough bone trabeculation (HP:0100670) | 1.77168542 |
| 123 | Relative macrocephaly (HP:0004482) | 1.77165241 |
| 124 | Abnormal cartilage morphology (HP:0002763) | 1.76516627 |
| 125 | Ependymoma (HP:0002888) | 1.76458955 |
| 126 | Abnormality of the Achilles tendon (HP:0005109) | 1.74415031 |
| 127 | Selective tooth agenesis (HP:0001592) | 1.74316436 |
| 128 | Hepatocellular carcinoma (HP:0001402) | 1.74314229 |
| 129 | Shoulder girdle muscle weakness (HP:0003547) | 1.73017724 |
| 130 | Periodontitis (HP:0000704) | 1.72628653 |
| 131 | Ankle contracture (HP:0006466) | 1.72145443 |
| 132 | Pelvic girdle muscle weakness (HP:0003749) | 1.71001708 |
| 133 | Bone pain (HP:0002653) | 1.70445695 |
| 134 | Trismus (HP:0000211) | 1.70199734 |
| 135 | Missing ribs (HP:0000921) | 1.70003132 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69899420 |
| 137 | Long palpebral fissure (HP:0000637) | 1.68515392 |
| 138 | Delayed cranial suture closure (HP:0000270) | 1.68433917 |
| 139 | Myositis (HP:0100614) | 1.68203198 |
| 140 | Cutaneous melanoma (HP:0012056) | 1.68169391 |
| 141 | Vascular calcification (HP:0004934) | 1.67635886 |
| 142 | Tibial bowing (HP:0002982) | 1.67087454 |
| 143 | Biliary tract neoplasm (HP:0100574) | 1.66831874 |
| 144 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.66444681 |
| 145 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.66444681 |
| 146 | Single umbilical artery (HP:0001195) | 1.66444681 |
| 147 | Deviation of the thumb (HP:0009603) | 1.66300278 |
| 148 | Abnormality of the calcaneus (HP:0008364) | 1.66003461 |
| 149 | Difficulty climbing stairs (HP:0003551) | 1.65775447 |
| 150 | Agnosia (HP:0010524) | 1.65766914 |
| 151 | Uterine neoplasm (HP:0010784) | 1.65536055 |
| 152 | Elfin facies (HP:0004428) | 1.65425209 |
| 153 | Neurofibrillary tangles (HP:0002185) | 1.65097812 |
| 154 | Generalized amyotrophy (HP:0003700) | 1.64927639 |
| 155 | Orthostatic hypotension (HP:0001278) | 1.64831073 |
| 156 | Flat acetabular roof (HP:0003180) | 1.64558208 |
| 157 | Achilles tendon contracture (HP:0001771) | 1.64486726 |
| 158 | Hypolipoproteinemia (HP:0010981) | 1.62325507 |
| 159 | Arterial thrombosis (HP:0004420) | 1.61580107 |
| 160 | Gingivitis (HP:0000230) | 1.61466881 |
| 161 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.60614828 |
| 162 | Disinhibition (HP:0000734) | 1.58633898 |
| 163 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.57913282 |
| 164 | Abnormality of complement system (HP:0005339) | 1.56282822 |
| 165 | Hypercholesterolemia (HP:0003124) | 1.53500991 |
| 166 | Cellulitis (HP:0100658) | 1.53338571 |
| 167 | Leiomyosarcoma (HP:0100243) | 1.52607465 |
| 168 | Uterine leiomyosarcoma (HP:0002891) | 1.52607465 |
| 169 | Pustule (HP:0200039) | 1.52470304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.30750325 |
| 2 | PKN2 | 2.95065695 |
| 3 | EPHA2 | 2.64353084 |
| 4 | ERN1 | 2.63279637 |
| 5 | CDK12 | 2.60617983 |
| 6 | MAP3K10 | 2.55140667 |
| 7 | TTN | 2.29427894 |
| 8 | EEF2K | 2.24163084 |
| 9 | SCYL2 | 2.11841436 |
| 10 | TBK1 | 1.99702971 |
| 11 | RIPK1 | 1.96386380 |
| 12 | BMX | 1.95191270 |
| 13 | PTK6 | 1.90903357 |
| 14 | STK10 | 1.80584043 |
| 15 | EIF2AK1 | 1.72134572 |
| 16 | RPS6KA4 | 1.70000614 |
| 17 | PBK | 1.62472530 |
| 18 | LIMK1 | 1.61891304 |
| 19 | LATS1 | 1.58950118 |
| 20 | SMG1 | 1.57906317 |
| 21 | LRRK2 | 1.54770375 |
| 22 | TSSK6 | 1.54641104 |
| 23 | PDGFRA | 1.53009466 |
| 24 | CDK6 | 1.50375686 |
| 25 | MAP3K14 | 1.49722680 |
| 26 | PAK4 | 1.43485097 |
| 27 | FLT3 | 1.39609176 |
| 28 | MAP3K12 | 1.36455650 |
| 29 | BUB1 | 1.34959471 |
| 30 | MYLK | 1.33333757 |
| 31 | TESK1 | 1.32625252 |
| 32 | MAP3K8 | 1.32546006 |
| 33 | MST1R | 1.31482550 |
| 34 | NTRK1 | 1.31095213 |
| 35 | FGFR4 | 1.30194576 |
| 36 | NEK2 | 1.28467351 |
| 37 | CDC7 | 1.27446596 |
| 38 | EIF2AK3 | 1.27052474 |
| 39 | ALK | 1.25219633 |
| 40 | DDR2 | 1.24475475 |
| 41 | RPS6KB2 | 1.24338430 |
| 42 | SIK1 | 1.24137790 |
| 43 | CDK8 | 1.23781496 |
| 44 | MOS | 1.19243409 |
| 45 | CHUK | 1.16150236 |
| 46 | NME2 | 1.13252333 |
| 47 | NEK1 | 1.12665892 |
| 48 | STK3 | 1.12525941 |
| 49 | MAP2K3 | 1.11699591 |
| 50 | MET | 1.11420959 |
| 51 | PTK2 | 1.09983386 |
| 52 | JAK3 | 1.08784360 |
| 53 | PIM2 | 1.07936704 |
| 54 | MAP3K3 | 1.06902648 |
| 55 | MTOR | 1.06887617 |
| 56 | TESK2 | 1.04073589 |
| 57 | CDK4 | 1.02297596 |
| 58 | PIM1 | 1.01726302 |
| 59 | TGFBR1 | 1.00826247 |
| 60 | BRSK2 | 1.00286448 |
| 61 | PDK2 | 1.00278470 |
| 62 | MAP3K11 | 0.98790395 |
| 63 | PASK | 0.98160216 |
| 64 | TGFBR2 | 0.97377308 |
| 65 | TYK2 | 0.95078541 |
| 66 | PAK2 | 0.92562970 |
| 67 | IKBKB | 0.90188279 |
| 68 | PRPF4B | 0.88887939 |
| 69 | IRAK3 | 0.86702103 |
| 70 | MST4 | 0.84665114 |
| 71 | NEK9 | 0.83516979 |
| 72 | CSK | 0.81909241 |
| 73 | LMTK2 | 0.81346122 |
| 74 | EPHB1 | 0.78976209 |
| 75 | ARAF | 0.77071643 |
| 76 | TTK | 0.76002476 |
| 77 | STK4 | 0.75464534 |
| 78 | LATS2 | 0.74919277 |
| 79 | KSR1 | 0.74166685 |
| 80 | ZAP70 | 0.71929256 |
| 81 | ABL2 | 0.71811075 |
| 82 | MAP3K5 | 0.67417807 |
| 83 | ERBB3 | 0.67223757 |
| 84 | PDGFRB | 0.66939059 |
| 85 | FGFR1 | 0.66535365 |
| 86 | FGFR3 | 0.66256050 |
| 87 | ICK | 0.65887096 |
| 88 | DYRK1B | 0.65744154 |
| 89 | MAP4K1 | 0.65481738 |
| 90 | CDK7 | 0.65126354 |
| 91 | STK38 | 0.64141739 |
| 92 | BRSK1 | 0.62560469 |
| 93 | BMPR2 | 0.61827394 |
| 94 | MATK | 0.61708288 |
| 95 | MAP3K9 | 0.61567961 |
| 96 | JAK1 | 0.60657347 |
| 97 | ILK | 0.59528171 |
| 98 | WEE1 | 0.59301017 |
| 99 | EGFR | 0.59202454 |
| 100 | AURKB | 0.58385062 |
| 101 | SRPK1 | 0.57909686 |
| 102 | EPHA3 | 0.57476414 |
| 103 | JAK2 | 0.57005910 |
| 104 | BLK | 0.56986100 |
| 105 | GRK7 | 0.54934599 |
| 106 | ACVR1B | 0.54465237 |
| 107 | TAOK3 | 0.53524470 |
| 108 | SIK3 | 0.53088059 |
| 109 | MAP2K2 | 0.52990440 |
| 110 | PRKG2 | 0.52468143 |
| 111 | CSF1R | 0.51507378 |
| 112 | TRPM7 | 0.50202541 |
| 113 | RIPK4 | 0.49774218 |
| 114 | CLK1 | 0.49391581 |
| 115 | CDK9 | 0.48833363 |
| 116 | GSK3A | 0.48776522 |
| 117 | BRAF | 0.48760502 |
| 118 | MAPKAPK3 | 0.47561482 |
| 119 | KSR2 | 0.47471068 |
| 120 | IKBKE | 0.46589243 |
| 121 | TAOK1 | 0.46366026 |
| 122 | MARK3 | 0.45944944 |
| 123 | RPS6KA1 | 0.44784780 |
| 124 | ROCK2 | 0.44742904 |
| 125 | HCK | 0.43589171 |
| 126 | MELK | 0.43003525 |
| 127 | AKT2 | 0.42954674 |
| 128 | TAOK2 | 0.42436938 |
| 129 | ATR | 0.42301038 |
| 130 | FER | 0.41828111 |
| 131 | MAPKAPK2 | 0.41773372 |
| 132 | FGR | 0.41674512 |
| 133 | MAP3K13 | 0.41631912 |
| 134 | MAP3K2 | 0.41040518 |
| 135 | AURKA | 0.40469297 |
| 136 | AKT3 | 0.39946317 |
| 137 | CHEK2 | 0.39564841 |
| 138 | CAMK2G | 0.35735528 |
| 139 | PLK1 | 0.35225846 |
| 140 | CHEK1 | 0.34830028 |
| 141 | IRAK2 | 0.34721714 |
| 142 | DMPK | 0.34007840 |
| 143 | PAK1 | 0.30283066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.36452545 |
| 2 | Legionellosis_Homo sapiens_hsa05134 | 2.26358057 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04788246 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.02930251 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75731169 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.67983550 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67223810 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.66439606 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66000504 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.65702897 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.64451084 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63998911 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.62913258 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61451397 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50988396 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.50643824 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48670851 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45644975 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40593618 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39537536 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38620412 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37779220 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.33613033 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33360671 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.32475281 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.31714076 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30477124 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.29198814 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.26988361 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.25978027 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.24593138 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22255214 |
| 33 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.21628723 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20918046 |
| 35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19128755 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17389201 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12066515 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.11831086 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11727189 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10926787 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.09213617 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.09085424 |
| 43 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.08953193 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08106919 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07855354 |
| 46 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.07054966 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06584314 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.06043918 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.04309128 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.02838149 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02250224 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01863076 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00647062 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.99724793 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99465189 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97623951 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95946110 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95319880 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95044766 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92461707 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92272330 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91880577 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90725738 |
| 64 | Prostate cancer_Homo sapiens_hsa05215 | 0.90220353 |
| 65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89737617 |
| 66 | RNA transport_Homo sapiens_hsa03013 | 0.89285515 |
| 67 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.88940670 |
| 68 | DNA replication_Homo sapiens_hsa03030 | 0.88687031 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.87803751 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87437260 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87358078 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87238276 |
| 73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.85171300 |
| 74 | * Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84044822 |
| 75 | Melanoma_Homo sapiens_hsa05218 | 0.81630961 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81474978 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80945783 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80515365 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80012122 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.79286298 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79143203 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.78891268 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.77964351 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76488468 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75745112 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75275007 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74827311 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.74789482 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.73313210 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72999701 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72587867 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72169048 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.71783165 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.71233871 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71154482 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69994228 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68484974 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68179085 |
| 99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67904080 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.67520881 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66251085 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.66004684 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65999602 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65600586 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.65578327 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65291935 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65198567 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.65089156 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64623379 |
| 110 | Tight junction_Homo sapiens_hsa04530 | 0.64384702 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64195190 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63924034 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63770235 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63751556 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63644640 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63265675 |
| 117 | Cell cycle_Homo sapiens_hsa04110 | 0.63230739 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62720665 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62200120 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61848619 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59894663 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59847565 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59707075 |
| 124 | Proteasome_Homo sapiens_hsa03050 | 0.58798171 |
| 125 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58763636 |
| 126 | Allograft rejection_Homo sapiens_hsa05330 | 0.58714352 |
| 127 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58147015 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57738749 |
| 129 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57609923 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57338674 |
| 131 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55863727 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55787462 |
| 133 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55099419 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54581504 |
| 135 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54190745 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54112282 |
| 137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50905673 |
| 138 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49517432 |
| 139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48857068 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47501933 |
| 141 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47102239 |
| 142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45668022 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44123356 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43260561 |

